Oprelvekin is recombinant interleukin eleven (IL-11), a thrombopoietic growth factor that directly stimulates the proliferation of hematopoietic stem cells and megakaryocyte progenitor cells and induces megakaryocyte maturation resulting in increased platelet production. It is marketed under the trade name Neumega.
Read more about Oprelvekin: Chemical, Pharmacological and Marketing Data, Indications, Contraindications and Precautions, Pregnancy, Lactation, Side Effects, Interactions, Necessary Examinations During Treatment, Dosage Regime, Additional Information, Information For Patients/'non-specialized' People